(0.16%) 5 222.68 points
(0.32%) 39 513 points
(-0.03%) 16 341 points
(-1.34%) $78.20
(-2.13%) $2.25
(1.14%) $2 366.90
(0.11%) $28.40
(1.48%) $1 005.50
(0.11%) $0.928
(-0.30%) $10.83
(-0.01%) $0.798
(-0.42%) $92.15
Live Chart Being Loaded With Signals
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary...
Stats | |
---|---|
Today's Volume | 296 322 |
Average Volume | 594 359 |
Market Cap | 110.18M |
EPS | $-0.280 ( 2021-11-15 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -0.694 |
ATR14 | $0.0990 (8.92%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2021-01-24 | Klein Christopher | Sell | 9 605 | Ordinary Shares |
2020-05-20 | Cowan Gregory L | Buy | 38 716 | Ordinary Shares |
2020-05-21 | Cowan Gregory L | Sell | 11 112 | Ordinary Shares |
2020-01-28 | Schaub James | Sell | 9 197 | Ordinary Shares |
2019-01-24 | Weiss Fred G | Buy | 34 403 | Ordinary Shares |
INSIDER POWER |
---|
0.00 |
Last 6 transactions |
Buy: 177 968 | Sell: 29 914 |
Volume Correlation
Osmotica Pharmaceuticals Correlation
10 Most Negative Correlations | |
---|---|
CFBK | -0.899 |
DOX | -0.871 |
ARDX | -0.87 |
GLBZ | -0.865 |
CERC | -0.853 |
FATP | -0.852 |
IMTX | -0.852 |
PBPB | -0.848 |
CRVS | -0.845 |
ECOR | -0.843 |
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Osmotica Pharmaceuticals Correlation - Currency/Commodity
Osmotica Pharmaceuticals Financials
Annual | 2022 |
Revenue: | $49.72M |
Gross Profit: | $40.27M (80.98 %) |
EPS: | $-0.580 |
FY | 2022 |
Revenue: | $49.72M |
Gross Profit: | $40.27M (80.98 %) |
EPS: | $-0.580 |
FY | 2020 |
Revenue: | $177.88M |
Gross Profit: | $103.40M (58.13 %) |
EPS: | $-1.520 |
FY | 2019 |
Revenue: | $240.03M |
Gross Profit: | $128.40M (53.49 %) |
EPS: | $-5.17 |
Financial Reports:
No articles found.
Osmotica Pharmaceuticals
Osmotica Pharmaceuticals plc, an integrated biopharmaceutical company, focuses on the development and commercialization of pharmaceutical products in the United States, Argentina, and Hungary. The company's promoted products include M-72, a methylphenidate hydrochloride extended-release tablet to treat attention deficit hyperactivity disorder (ADHD); Osmolex ER, an amantadine extended-release tablet for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions in adults; Arbaclofen extended-release tablets which is in phase III clinical trial for the treatment of multiple sclerosis spasticity; Upneeq, an oxymetazoline hydrochloride ophthalmic solution for the treatment of Blepharoptosis; and OS870 which is in Phase I clinical trial for the treatment of neurodegenerative disorders. It also provides women's health products, including Divigel for menopause; and OB Complete, a dietary supplement for prenatal, pregnancy, and postnatal periods. In addition, the company's non-promoted products comprise methylphenidate ER tablets for ADHD; venlafaxine ER tablets to treat major depressive disorders and social anxiety disorders; hydromorphone ER for treating pain; nifedipine ER for hypertension; sodium benzoate/sodium phenylacetate for the treatment of hyperammonemia; oxybutynin ER for overactive bladder; prescription prenatal vitamins for treating nutritional requirements during pregnancy; Lorzone, an immediate-release form of chlorzoxazone indicated for the treatment of acute musculoskeletal pain in conjunction with rest and physical therapy; ConZip, a tramadol hydrochloride for the management of pain; and nitrofurantoin for the treatment of urinary tract infections, as well as Osmodex and other abbreviated new drug applications. Osmotica Pharmaceuticals plc is headquartered in Bridgewater, New Jersey.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators